Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Chemotherapy-induced Peripheral Neuropathy in Cancer Patients Using a Combined Qigong Baduanjin and Self-administered Acupressure Intervention: A Randomized Controlled Trial

NCT05764447 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05764447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Chemotherapy-induced Peripheral Neuropathy in Cancer Patients Using a Combined Qigong Baduanjin and Self-administered Acupressure Intervention: A Randomized Controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2023
Completion date
March 31, 2025
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemotherapy-induced peripheral neuropathy